Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Slusher

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Developmental Neuroscience|March 29, 2023
Dendrimer-Conjugated Glutamate Carboxypeptidase II Inhibitor Restores Microglial Changes in a Rabbit Model of Cerebral PalsyNirnath Sah, Zhi Zhang, Alicia Chime, et al.
Journal of Biomolecular Screening|July 4, 2012
Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase IIGlenda Alquicer, David Sedlák, Youngjoo Byun, et al.
Journal of Neurotrauma|April 13, 2018
Enhancement of Brain d-Serine Mediates Recovery of Cognitive Function after Traumatic Brain InjurySigal Liraz-Zaltsman, Barbara Slusher, Dana Atrakchi-Baranes, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Inhibition of Glutamine Metabolism Suppresses Tumor Progression through Remodeling of the Macrophage Immune MicroenvironmentTianhe Li, Sepehr Akhtarkhavari, Tu-Yung Chang, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 22, 2021
Development of EQ-6, a Novel Analogue of Ethoxyquin to Prevent Chemotherapy-Induced Peripheral NeuropathyAysel Cetinkaya-Fisgin, Jing Zhu, Xinghua Luan, et al.
Biochemical Pharmacology|December 1, 2009
Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat modelHanna Shevalye, Roman Stavniichuk, Weizheng Xu, et al.
Endocrinology|April 2, 2010
New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}Viktor R Drel, Sergey Lupachyk, Hanna Shevalye, et al.
Nature Reviews. Neurology|March 12, 2016
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentDeanna Saylor, Alex M Dickens, Ned Sacktor, et al.
Nature Reviews. Neurology|April 16, 2016
HIV-associated neurocognitive disorder - pathogenesis and prospects for treatmentDeanna Saylor, Alex M Dickens, Ned Sacktor, et al.
Free Radical Biology & Medicine|November 3, 2007
PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathyIrina G Obrosova, Weizheng Xu, Valeriy V Lyzogubov, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Developmental Neuroscience|March 29, 2023
Dendrimer-Conjugated Glutamate Carboxypeptidase II Inhibitor Restores Microglial Changes in a Rabbit Model of Cerebral PalsyNirnath Sah, Zhi Zhang, Alicia Chime, et al.
Journal of Biomolecular Screening|July 4, 2012
Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase IIGlenda Alquicer, David Sedlák, Youngjoo Byun, et al.
Journal of Neurotrauma|April 13, 2018
Enhancement of Brain d-Serine Mediates Recovery of Cognitive Function after Traumatic Brain InjurySigal Liraz-Zaltsman, Barbara Slusher, Dana Atrakchi-Baranes, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Inhibition of Glutamine Metabolism Suppresses Tumor Progression through Remodeling of the Macrophage Immune MicroenvironmentTianhe Li, Sepehr Akhtarkhavari, Tu-Yung Chang, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 22, 2021
Development of EQ-6, a Novel Analogue of Ethoxyquin to Prevent Chemotherapy-Induced Peripheral NeuropathyAysel Cetinkaya-Fisgin, Jing Zhu, Xinghua Luan, et al.
Biochemical Pharmacology|December 1, 2009
Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat modelHanna Shevalye, Roman Stavniichuk, Weizheng Xu, et al.
Endocrinology|April 2, 2010
New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}Viktor R Drel, Sergey Lupachyk, Hanna Shevalye, et al.
Nature Reviews. Neurology|March 12, 2016
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentDeanna Saylor, Alex M Dickens, Ned Sacktor, et al.
Nature Reviews. Neurology|April 16, 2016
HIV-associated neurocognitive disorder - pathogenesis and prospects for treatmentDeanna Saylor, Alex M Dickens, Ned Sacktor, et al.
Free Radical Biology & Medicine|November 3, 2007
PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathyIrina G Obrosova, Weizheng Xu, Valeriy V Lyzogubov, et al.
Pageof 4